• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用包括高压氧疗法在内的多种治疗方法联合治疗钙化性尿毒症小动脉病(钙化防御)。

Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy.

作者信息

Arenas M D, Gil M T, Gutiérrez M D, Malek T, Moledous A, Salinas A, Alvarez-Ude F

机构信息

Servicio de Nefrologia, Hospital Perpetuo Socorro, Alicante, Spain.

出版信息

Clin Nephrol. 2008 Sep;70(3):261-4. doi: 10.5414/cnp70261.

DOI:10.5414/cnp70261
PMID:18793571
Abstract

Calcific uremic arteriolopathy (CUA) is a rare but serious complication of end-stage renal disease presenting as painful cutaneous lesions and progressing to non-healing ulcers and gangrene. This syndrome is associated with calcium and phosphorus deposits within small arteries of the skin. The pathognomonic lesion is vascular calcification with intimal arterial hypertrophy and superimposed small-vessel thrombosis. The condition is being increasingly recognized and reported as a contributing factor to death in dialysis patients, with secondary infection and sepsis as the major cause of mortality. No standard treatment has been established for this syndrome. We present the therapeutic approach employed in two patients, which successfully resulted in healing of the lesions, using a combination of measures to control the factors potentially related to development of CUA and hyperbaric oxygen therapy.

摘要

钙化性尿毒症性小动脉病(CUA)是终末期肾病的一种罕见但严重的并发症,表现为疼痛性皮肤病变,并进展为不愈合的溃疡和坏疽。该综合征与皮肤小动脉内的钙和磷沉积有关。其特征性病变是血管钙化伴内膜动脉肥厚和叠加的小血管血栓形成。这种疾病越来越被认为是透析患者死亡的一个促成因素,继发感染和脓毒症是主要死亡原因。目前尚未确立针对该综合征的标准治疗方法。我们介绍了两名患者所采用的治疗方法,通过综合采取措施控制可能与CUA发生相关的因素并结合高压氧治疗,成功使病变愈合。

相似文献

1
Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy.采用包括高压氧疗法在内的多种治疗方法联合治疗钙化性尿毒症小动脉病(钙化防御)。
Clin Nephrol. 2008 Sep;70(3):261-4. doi: 10.5414/cnp70261.
2
Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.钙化防御相关皮肤沉积物在钙化性尿毒症性小动脉病患者中的定位、形态特征和化学成分。
JAMA Dermatol. 2019 Jul 1;155(7):789-796. doi: 10.1001/jamadermatol.2019.0381.
3
[Calcific uremic arteriolopathy (Calcyphilaxis): a rare disease? Report of three cases].[钙化性尿毒症性小动脉病(钙沉着症):一种罕见疾病?三例报告]
G Ital Nefrol. 2015 Jan-Feb;32(1).
4
Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series.高压氧疗法治疗钙化性尿毒症小动脉病:病例系列
J Nephrol. 2002 Nov-Dec;15(6):676-80.
5
Calcific uremic arteriolopathy ameliorated by hyperbaric oxygen therapy in high-altitude area.高压氧治疗改善高原地区钙化性尿毒症小动脉病
Ren Fail. 2014 Aug;36(7):1139-41. doi: 10.3109/0886022X.2014.917672. Epub 2014 May 15.
6
Calcific uremic arteriolopathy: advances in pathogenesis and treatment.钙化性尿毒症小动脉病:发病机制与治疗进展
Semin Dial. 2007 Mar-Apr;20(2):150-7. doi: 10.1111/j.1525-139X.2007.00263.x.
7
Calciphylaxis: a systematic review of existing and emerging therapies.钙化防御:现有和新兴疗法的系统评价。
J Am Acad Dermatol. 2012 Dec;67(6):e253-60. doi: 10.1016/j.jaad.2011.06.009. Epub 2011 Aug 6.
8
A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies.一种采用多种治疗方法联合治疗钙化性尿毒症小动脉病(钙化防御)的策略。
Clin Nephrol. 2003 Jun;59(6):463-70. doi: 10.5414/cnp59463.
9
Calcific uremic arteriolopathy: a call for action.钙化性尿毒症小动脉病:行动呼吁。
Semin Nephrol. 2014 Nov;34(6):641-7. doi: 10.1016/j.semnephrol.2014.09.007.
10
Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment.钙化性尿毒症小动脉病(钙化防御)对诊断和治疗指南的有效性提出了质疑。
J Dermatolog Treat. 2020 Aug;31(5):545-548. doi: 10.1080/09546634.2019.1618435. Epub 2019 May 31.

引用本文的文献

1
Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.慢性肾脏病中钙敏感受体病的治疗:一项系统评价和荟萃分析。
Kidney Int Rep. 2018 Oct 9;4(2):231-244. doi: 10.1016/j.ekir.2018.10.002. eCollection 2019 Feb.
2
Non-Uremic Calciphylaxis: A Rare Diagnosis with Limited Therapeutic Strategies.非尿毒症性钙化防御:一种诊断罕见且治疗策略有限的疾病。
Eur J Case Rep Intern Med. 2018 Dec 27;5(12):000986. doi: 10.12890/2018_000986. eCollection 2018.
3
Non-uraemic calciphylaxis successfully treated with pamidronate infusion.
非尿毒症性钙磷沉积症经帕米膦酸二钠输注治疗后成功缓解。
Int Wound J. 2019 Feb;16(1):250-255. doi: 10.1111/iwj.13019. Epub 2018 Nov 4.
4
Calciphylaxis in Patients With Preserved Kidney Function.肾功能正常患者的钙过敏症
J Am Coll Clin Wound Spec. 2015 Aug 7;6(1-2):24-8. doi: 10.1016/j.jccw.2015.08.002. eCollection 2014 Apr.
5
Update on cutaneous calciphylaxis.皮肤钙化防御的最新进展。
Indian J Dermatol. 2013 Mar;58(2):87-92. doi: 10.4103/0019-5154.108026.
6
Calcific uremic arteriolopathy on multimodal combination therapy: still unmet goal.多模式联合治疗钙化性尿毒症小动脉病:目标仍未达成
Int J Nephrol. 2012;2012:390768. doi: 10.1155/2012/390768. Epub 2012 Feb 20.
7
[Cutaneous calciphylaxis].[皮肤钙化防御]
Hautarzt. 2010 Dec;61(12):1063-71; quiz 1072. doi: 10.1007/s00105-010-2026-4.
8
Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess.常氧加压治疗伴肾周脓肿的常染色体显性多囊肾病患者。
Clin Exp Nephrol. 2011 Feb;15(1):141-6. doi: 10.1007/s10157-010-0348-2. Epub 2010 Oct 1.
9
Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.钙化尿毒症性小动脉病:病理生理学、活性氧物质和治疗方法。
Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21. doi: 10.4161/oxim.3.2.11354.